Description

Celator Pharmaceuticals is working on developing new therapies to treat cancer. Research at Celator identifies synergistic ratios of drugs to improve tumor cell kill and locks the synergistic ratio in a drug delivery vehicle to maintain the ratio in patients. The goal of this approach is to improve the therapeutic benefit these drugs provide patients.

We teamed up with Berry and Company, a New York City based Public Relations firm specializing in PR for the Health Care industry. Among the projects we teamed up together with were a new website that promoted the research and therapies to the audiences of Investors and Scientists. In addition we developed corporate fact sheets.